Answers are grounded in this paper and cite their sources.
We report a compact high-power yellow laser system for the treatment of cutaneous vascular lesions, such as telangiectasia and port wine stains. The system is based on optically pumped vertical-external-cavity surface-emitting lasers (VECSELs), which have emerged as an attractive alternative to solid-state and dye lasers due to their enhanced functionality and broad wavelength coverage. The reported system is capable of delivering up to 8 W of output power at ~590 nm and includes a handheld scanner for an easy delivery of light onto the skin. The scan area can be varied from a single spot (1.4-mm diameter) up to 49 spots covering an area of 1 cm2. Additional features include adjustable fluence (0-52 J/cm2), scan patterns (line, square, hexagon), and pulse length (10-100 ms). The system has been qualified for and is currently used in a clinical trial concerning the treatment of facial telangiectasia (ClinicalTrials.gov Identifier: NCT03472859). Preliminary results of the test are reported indicating reduced treatment time for the yellow system and power reserve that could lead to further increase of the area treated in a single scan.
No takes yet. Share an insight, caveat, or question.
Kantola et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: